Earnings History Data for Epizyme, Inc. (EPZM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Epizyme, Inc.

Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-08-2022	PM		EPZM	Epizyme, Inc.	250.81	-0.21	-0.36	-0.63	Epizyme GAAP EPS of -$0.21, revenue of $27.5M [8/9/2022 8:29 AM]	1.48	0.01 (0.68%)	1.47	0.0 (0.00%)	0.41 - 6.15	2,309,580	2,270,000	4,696
Epizyme GAAP EPS of -$0.21, revenue of $27.5M [8/9/2022 8:29 AM] Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-22 08:25AM] Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-09-22 07:00AM]
10-05-2022	PM	7:00 AM ET (May 10)	EPZM	Epizyme, Inc.	109.19	-0.39	-0.35	-0.69	Epizyme GAAP EPS of -$0.38 misses by $0.03, revenue of $8.69M misses by $1.33M [5/10/2022 7:05 AM]	0.6173	0.0 (-0.77%)	0.62	0.0 (-0.50%)	0.59 - 9.86	1,120,428	2,290,746	6,778
Epizyme Q1 2022 Earnings Preview [5/9/2022 12:10 PM] Epizyme GAAP EPS of -$0.38 misses by $0.03, revenue of $8.69M misses by $1.33M [5/10/2022 7:05 AM] Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 06:25PM] Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update [May-10-22 07:00AM] Epizyme (EPZM) Reports Q1 Loss, Lags Revenue Estimates [May-10-22 08:15AM]
01-03-2022	PM	6:30 AM ET (Mar 1)	EPZM	Epizyme, Inc.	240.89	-0.49	-0.41	-0.65	Epizyme GAAP EPS of -$0.49 misses by $0.08, revenue of $11.6M misses by $8.82M [3/1/2022 7:11 AM]	1.56	0.08 (5.03%)	1.26	-0.23 (-15.43%)	1.01 - 9.93	2,615,507	2,830,000	84,477
Epizyme GAAP EPS of -$0.49 misses by $0.08, revenue of $11.6M misses by $8.82M [3/1/2022 7:11 AM] Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-01-22 07:00AM] Epizyme (EPZM) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-22 09:05AM]
09-11-2021	PM	7:30 AM ET (Nov 9)	EPZM	Epizyme, Inc.	487.73	-0.64	-0.45	-0.55	Epizyme EPS misses by $0.11, misses on revenue [11/9/2021 6:35 AM]	4.86	-0.12 (-2.41%)	4.90	-0.08 (-1.61%)	4.08 - 14.30	742,427	1,030,000	6,330
Epizyme Q3 2021 Earnings Preview [11/8/2021 1:03 PM] Epizyme EPS misses by $0.11, misses on revenue [11/9/2021 6:35 AM] Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-09-21 06:30AM] Epizyme (EPZM) Reports Q3 Loss, Misses Revenue Estimates [Nov-09-21 07:45AM] Epizyme, inc (EPZM) Q3 2021 Earnings Call Transcript [Nov-09-21 03:30PM]
09-08-2021	PM	6:30 AM ET (Aug 9)	EPZM	Epizyme, Inc.	672.02	-0.63	-0.60	-0.58	Epizyme EPS misses by $0.02, beats on revenue [8/9/2021 7:36 AM]	5.86	-0.61 (-9.51%)	5.59	-0.88 (-13.60%)	5.60 - 14.30	3,846,687	1,000,000	436,127
Hutchmed inks Tazverik development deal with Epizyme in Greater China [8/9/2021 12:01 AM] Epizyme EPS misses by $0.02, beats on revenue [8/9/2021 7:36 AM] Epizyme CEO Robert Bazemore steps down [8/9/2021 8:12 AM] Epizyme Announces CEO Succession [Aug-09-21 07:35AM] Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-09-21 07:30AM] Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-21 08:45AM] Epizyme, inc (EPZM) Q2 2021 Earnings Call Transcript [Aug-09-21 06:30PM] Why Epizyme Is Getting Crushed Today [Aug-09-21 04:55PM]
06-05-2021	PM	6:30 AM ET (May 6)	EPZM	Epizyme, Inc.	773.57	-0.69	-0.56	-0.51	Epizyme EPS misses by $0.12, beats on revenue [5/6/2021 6:34 AM]	6.81	-0.71 (-9.44%)	6.81	0.0 (0.00%)	6.70 - 22.00	2,370,122	1,100,000	186
Epizyme EPS misses by $0.12, beats on revenue [5/6/2021 6:34 AM] Epizyme Provides Business Update and Reports First Quarter 2021 Financial Results [May-06-21 06:30AM] Epizyme (EPZM) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 08:05AM]
23-02-2021	PM	6:30 AM ET (Feb 23)	EPZM	Epizyme, Inc.	1,080	-0.65	-0.59	-0.59	Epizyme EPS misses by $0.06, beats on revenue [2/23/2021 6:32 AM]	10.41	-0.28 (-2.62%)	10.00	-0.69 (-6.45%)	9.90 - 23.61	1,310,680	768,177	18,799
Epizyme EPS misses by $0.06, beats on revenue [2/23/2021 6:32 AM] Epizyme Q4 2020 Earnings Preview [2/22/2021 1:32 PM] Epizyme Q4 top-line down 95%, Tazverik revenues reach $4.5M [2/23/2021 6:57 AM] Epizyme Inc (EPZM) Q4 2020 Earnings Call Transcript [Feb-23-21 08:00PM] Return On Capital Employed Overview: Epizyme [Feb-23-21 10:04AM] Epizyme, Inc. to Host Earnings Call [Feb-23-21 06:15AM]
06-11-2020	PM	6:30 AM ET (Nov 6)	EPZM	Epizyme, Inc.	1,330	-0.55	-0.61	-0.40	Epizyme EPS beats by $0.06, misses on revenue [11/6/2020 6:35 AM]	10.34	-3.22 (-23.73%)	10.49	-3.06 (-22.58%)	9.90 - 27.82	3,699,695	681,200	158,934

04-08-2020	PM	6:30 AM ET (Aug 4)	EPZM	Epizyme, Inc.	1,400	-0.58	-0.56	-0.53	Epizyme EPS misses by $0.01, misses on revenue [8/4/2020 6:31 AM]	13.02	-1.35 (-9.39%)	14.10	-0.27 (-1.88%)	9.74 - 27.82	1,175,475	972,110	5,187